SNN Stock Declines Despite the Launch of Its Patient-Matched Guides

Zacks09-14

Smith & Nephew SNATS SNN recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467170420?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795","is_english":true,"pubTime":"2024-09-14 00:21","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2467170420","market":"us","top_or_hot":-1,"title":"SNN Stock Declines Despite the Launch of Its Patient-Matched Guides","media":"Zacks","content":"<div>\n<p>Smith & Nephew SNATS SNN recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/snn-stock-declines-despite-launch-162100534.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SNN Stock Declines Despite the Launch of Its Patient-Matched Guides</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSNN Stock Declines Despite the Launch of Its Patient-Matched Guides\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-14 00:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/snn-stock-declines-despite-launch-162100534.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Smith & Nephew SNATS SNN recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/snn-stock-declines-despite-launch-162100534.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健护理机构","start_time":0,"source_url":"https://finance.yahoo.com/news/snn-stock-declines-despite-launch-162100534.html","article_id":"2467170420","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467170420","pubTimestamp":1726244460,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Smith & Nephew SNATS SNN recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and perform total ankle replacement procedures.TOTAL ANKLE Patient-Matched Guides are engineered using 3D Systems’ VSPsurgical planning workflows and are designed to achieve a precise patient fit using fluoroscopic alignment cues and efficient instrumentation, and provide accuracy to plan.However, shares of SNN lost 0.6% on Sept. 13 despite the launch of the TOTAL ANKLE Patient-Matched Guides.Smith & Nephew collaborated with 3D Systems, a company based in South Carolina, to assist in the design and production of the TOTAL ANKLE Patient-Matched Guides. The guides also have compatibility with chamfer talar implants for Smith & Nephew’s Cadence Total Ankle System and Salto Talaris total ankle prosthesis. This provides surgeons with the versatility of implant choice for their patients.Per a report by Gr","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","BK4585":"ETF&股票定投概念","UHS":"Universal Health Services Inc Cl","BK4567":"ESG概念","BK4120":"环境与设施服务","ABM":"反导工业公司","BK4588":"碎股","BK4583":"猴痘概念","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","SNN":"Smith & Nephew PLC ADS","BK4082":"医疗保健设备","BK4196":"保健护理服务","DGX":"奎斯特诊疗","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC"},"translate_title":"尽管推出了与患者匹配的指南，SNN股价仍下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1,"SNN":1,"UHS":1,"ABM":0.9},"content_text":"Smith & Nephew SNATS SNN recently announced the launch of its TOTAL ANKLE Patient-Matched Guides. These guides are likely to provide surgeons with a predictable and efficient option to plan and perform total ankle replacement procedures.\nTOTAL ANKLE Patient-Matched Guides are engineered using 3D Systems’ VSP surgical planning workflows and are designed to achieve a precise patient fit using fluoroscopic alignment cues and efficient instrumentation, and provide accuracy to plan.\nHowever, shares of SNN lost 0.6% on Sept. 13 despite the launch of the TOTAL ANKLE Patient-Matched Guides.\nMore on SNN’s TOTAL ANKLE Patient-Matched Guides\nSmith & Nephew collaborated with 3D Systems, a company based in South Carolina, to assist in the design and production of the TOTAL ANKLE Patient-Matched Guides. The guides also have compatibility with chamfer talar implants for Smith & Nephew’s Cadence Total Ankle System and Salto Talaris total ankle prosthesis. This provides surgeons with the versatility of implant choice for their patients.\nPer both companies, all-in-one Total Ankle Patient-Matched, 3D-printed guidelines assist in achieving an exact patient fit. It also provides accuracy for a plan by utilizing fluoroscopic alignment cues and effective instruments. The user-friendly system provides tactile feedback with medical arm wrap and precise patient fit.\nSNN’s Recent Collaborations & Product Launches\nIn August, SNN and InfuSystem Holdings announced a three-year distribution agreement for delivering Smith & Nephew's innovative RENASYS EDGE negative pressure wound therapy system to patients requiring home-based care for chronic wounds. The collaboration aims to enhance patient access to advanced wound care technology, leveraging InfuSystem’s extensive network and service capabilities.\nIn the same month, SNN also announced an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company (HOPCo) – the world’s largest, fully integrated, musculoskeletal value-based care and outcomes management company. The collaboration is likely to enhance solutions for Ambulatory Surgical Center’s customers, physicians, and patients through HOPCo’s digital health and analytics platforms, myrecovery and Vitals.\nIn July, SNN announced the receipt of FDA 510(k) clearance for its new CATALYSTEM Primary Hip System. The system is made to meet the changing needs of primary hip surgery, such as the growing popularity of anterior approach procedures and the growing significance of ambulatory surgery centers.\nIn June, the company announced the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services. This launch is likely to provide personalized solutions for surgeons and patients across partial and total knee arthroplasty procedures.\nFavorable Industry Prospects for SNN\nPer a report by Grand View Research, the global total ankle replacement market size was $709.7 million in 2023 and is projected to witness a CAGR of 8.62% from 2024-2030.\nThe increasing prevalence of weakened bones & reduced bone density, coupled with the growing incidence of musculoskeletal disorders, is driving the demand for total ankle replacement therapies. In addition, the growing availability of advanced ankle replacement options and rapidly developing healthcare infrastructure are anticipated to impact market growth positively.\nSNN'S Price Performance\nIn the past six months, SNN’s shares have gained 14.1% compared with the industry’s growth of 7.6%. The S&P 500 increased 8.6% in the same time frame.\nImage Source: Zacks Investment Research\nSNN’s Zacks Rank & Stocks to Consider\nSNN carries a Zacks Rank #3 (Hold) at present.\nSome better-ranked stocks in the broader medical space are Universal Health Service UHS, Quest Diagnostics DGX and ABM Industries ABM. While Universal Health Service sports a Zacks Rank #1 (Strong Buy), Quest Diagnostics and ABM Industries carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.\nUniversal Health Service has an estimated long-term growth rate of 19%. UHS’ earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.\nUniversal Health Service has gained 41.1% compared with the industry's 34.8% rise so far this year.\nQuest Diagnostics has an estimated long-term growth rate of 6.20%. DGX’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 3.31%.\nQuest Diagnostics shares have gained 3.7% so far this year compared with the industry’s 10.2% rise.\nABM Industries’ earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 7.34%.\nABM's shares have risen 24.1% so far this year compared with the industry’s 11.9% growth.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nQuest Diagnostics Incorporated (DGX) : Free Stock Analysis Report\nUniversal Health Services, Inc. (UHS) : Free Stock Analysis Report\nSmith & Nephew SNATS, Inc. (SNN) : Free Stock Analysis Report\nABM Industries Incorporated (ABM) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467170420"}